Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4245714
Max Phase: Preclinical
Molecular Formula: C28H39N3O5
Molecular Weight: 497.64
Molecule Type: Small molecule
Associated Items:
ID: ALA4245714
Max Phase: Preclinical
Molecular Formula: C28H39N3O5
Molecular Weight: 497.64
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C=C1C(=O)[C@]23[C@H](O)[C@H]1C[C@H](O)[C@H]2[C@]12CCCC(C)(C)[C@H]1C[C@H]3O[C@@H]2OCCn1cc(CC2CC2)nn1
Standard InChI: InChI=1S/C28H39N3O5/c1-15-18-12-19(32)22-27-8-4-7-26(2,3)20(27)13-21(28(22,23(15)33)24(18)34)36-25(27)35-10-9-31-14-17(29-30-31)11-16-5-6-16/h14,16,18-22,24-25,32,34H,1,4-13H2,2-3H3/t18-,19-,20+,21+,22-,24+,25-,27-,28+/m0/s1
Standard InChI Key: JRMNIPVKPOKUEE-RFKZTKOISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 497.64 | Molecular Weight (Monoisotopic): 497.2890 | AlogP: 2.67 | #Rotatable Bonds: 6 |
Polar Surface Area: 106.70 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 0.47 | CX LogP: 2.88 | CX LogD: 2.88 |
Aromatic Rings: 1 | Heavy Atoms: 36 | QED Weighted: 0.58 | Np Likeness Score: 2.10 |
1. Ke Y, Wang W, Zhao LF, Liang JJ, Liu Y, Zhang X, Feng K, Liu HM.. (2018) Design, synthesis and biological mechanisms research on 1,2,3-triazole derivatives of Jiyuan Oridonin A., 26 (17): [PMID:30143365] [10.1016/j.bmc.2017.11.005] |
Source(1):